Lakeland Regional Cancer Center is pleased to provide the community with the finest cancer specialists in the area. Each of our physicians and surgeons is fellowship-trained in their area of expertise.
Dr. Bandyk is a Board Certified, Fellowship Trained Urologic Oncologist. He has degrees from The University of Michigan and a medical degree from George Washington University School of Medicine. He completed surgical training at the University of Pittsburgh; University of California, San Francisco; Columbia University; and MD Anderson Cancer Center, University of Texas. In addition, he completed laboratory and clinical research at the University of Michigan, National Institutes of Health and the Salk Institute.
Dr. Bandyk helped establish the robotic surgery program at Lakeland Regional Medical Center in August, 2004. He is an expert in robotic surgery including radical prostatectomy, partial and total nephrectomy and reconstructive surgery.
Dr. Bandyk has a special interest in prostate, renal, bladder and adrenal cancers. In addition, he has extensive experience in minimally invasive surgery for stone disease.
Dr. Graham Greene is the leader of LRCC’s Prostate Cancer Center of Excellence and a Fellowship Trained Urologic Oncologist. He has published numerous works and has participated in multiple clinical trials during his career. Dr. Greene is certified by the American Urologic Association and a Fellow of both the American College of Surgeons and the Royal College of Surgeons of Canada.
Dr. Greene comes to LRCC most recently from the University of Arkansas, where he was Chief of Urologic Oncology for 10 years and held the position of the Robert Woods Bass Chair in Urologic Oncology. He received his medical degree from Dalhousie University in Halifax, Nova Scotia, where he also completed an internship and residency and served as the Chief Resident in Urology. He completed his fellowship in urologic oncology at MD Anderson Cancer Center, University of Texas, in Houston.
Dr. Greene’s specialties include treating locally and advanced bladder cancer, reconstructive surgery building orthotopic neobladders, advanced kidney cancer surgery and robotic prostatectomies. In addition, he has extensive experience in testicular cancer, penile cancer and surgical removal of retroperitoneal sarcomas.
Dr. Hodge received his medical degree from Duke University School of Medicine. He received extensive postgraduate training at Duke University Medical Center in General and Thoracic Surgery and then in Urologic Surgery. He served a Urologic Oncology Fellowship at MD Anderson Hospital and Tumor Institute. He was the first Chief of Urology at Moffitt Cancer Center in Tampa and was Director of Urologic Oncology at the Cancer Institute at Florida Hospital prior to coming to Lakeland Regional Cancer Center.
Dr. Hodge is the principal investigator for LRCC’s urologic clinical trials program and specializes in bladder reconstruction, erectile dysfunction and minimally invasive therapies for prostate and kidney cancers. He has extensive experience in cryosurgical ablation of small kidney tumors and cryosurgical treatment for prostate cancers. His interests include HIFU (High Intensity Focal Ultrasound), for focal treatment of prostate cancer.
Dr. Hodge is a well-known and respected speaker, writer, consultant and physician throughout Central Florida. Dr. Hodge has certificates from the National Board of Medical Examiners, the American Board of Urology and the American Board of Quality Assurance and Utilization Review. He is an active member in numerous professional organizations including The American Cancer Society and has served on a variety of hospital and association committees.
Dr. Frances Martin is a Fellowship Trained Urologic Oncologist who received her medical degree from the University of Alabama (UAB) School of Medicine in Birmingham. She completed her Urological Surgery residency at the University of Kentucky, Chandler Medical Center in Lexington. After her residency, she completed a fellowship and was a clinical specialist in the Department of Urologic Oncology at MD Anderson Cancer Center, University of Texas.
Dr. Martin was the Bobby C. Powell Intern of the Year during her General Surgery internship at the University of Kentucky. She also received the Medical Student Enrichment Program Travel Award for training in Russia while at UAB. In addition, Dr. Martin has completed multiple research projects in areas of urologic oncology, urologic stone disease and gynecology among others. She graduated with honors from Vanderbilt University with a B.S. in Biology and English.
Dr. Martin is a member of the medical honor society of Alpha Omega Alpha, The American Medical Association and The Society for Urologic Oncology. Dr. Martin has written numerous publications and is involved with many civic organizations.
Dr. Martin specializes in minimally invasive procedures, both laparoscopic and robotic, including partial nephrectomies, radical nephrectomies and radical prostatectomies. In addition, she has a primary interest in localized and advanced bladder cancer.
Dr. Matthew Smith is a Board Certified Urologist and a Fellow in the American College of Surgeons. Upon completion of his medical degree at Georgetown University School of Medicine, Dr. Smith completed his internship at the University of California Medical Center in San Francisco, his general surgery training at the Hospital of the University of Pennsylvania and his urology training at Duke University Medical Center. He also completed fellowship programs at Duke University Medical Center in Urologic Oncology and the Eastern Virginia Graduate School of Medicine in Pediatric and Reconstructive Surgery. During this time, he held multiple academic appointments.
Dr. Smith is a member of numerous professional societies, including The American Urologic Association, The American Association of Clinical Urologists, The International Society of Urologic Surgeons, American College of Surgeons, The Society of Genitourinary Reconstructive Surgery and the medical honor society, Alpha Omega Alpha.
Dr. Smith has published several scientific papers and has contributed to chapters in several urologic text books. His specialties include open nerve sparing radical prostatectomy, open partial nephrectomies, open radical nephrectomies, cryosurgery for prostate cancer and brachytherapy for prostate cancer. In addition, he practices general urology and specializes in penile prostatic surgery for impotence and artificial urinary sphincter placement for urinary incontinence.
Dr. Chan is a Surgical Oncologist with Board Certification in Surgery. She comes to Lakeland Regional Cancer Center from Southern California Kaiser Permanente Medical Group, where she received the honor of 2002 Physician of the Year at Kaiser Riverside Medical Center. Prior to that, she worked at Northern California Kaiser Permanente Medical Group as Staff Surgical Oncologist and Staff Thoracic Oncologic Surgeon. During this time she was also an Associate Clinical Professor at the University of California San Francisco.
Dr. Chan attended Medical School at Johns Hopkins University School of Medicine. Her postgraduate training includes a Residency in General Surgery at Huntington Memorial Hospital in Pasadena, CA and a Fellowship in Oncologic Surgery at Mount Sinai Medical Center in Miami Beach, FL.
Dr. Chan has published her research in numerous papers and contributed to several medical articles.
Dr. Molina is a board-certified surgical oncology specialist. His multi-area surgical expertise includes malignant and benign hepato-biliary and pancreatic diseases, melanoma, sarcoma, esophageal cancer, gastric cancer and other digestive tract cancers.
Dr. Molina brings expertise in minimally-invasive laparoscopic procedures for esophageal, stomach, pancreatic, liver, bile duct and colon cancers. He also has a special interest in endocrine surgeries.
Upon completion of his medical degree from Facultad de Medicina Universidad de Panama; surgery internship at Montefiore Medical Center in Bronx, NY; surgery residency from SUNY Health Science Center at Brooklyn, NY; and surgical oncology fellowship at the University of Miami/Jackson Memorial Hospital, Dr. Molina joined Surgical Associates of Palm Beach County in Boca Raton. He also served as Director of Surgical Oncology at the Lynn Cancer Institute in Boca Raton.
In 2008, Dr. Molina was named to America’s Top Surgeons by the Consumers’ Research Council of America. He also received the Alfred S. Ketcham M.D. award for superior performance as a surgical oncology fellow in 2008 from the University of Miami, FL and the Thomas W. Pollock M.D. excellence award as a surgery resident in 2006 from SUNY Downstate Medical Center.
Dr. Molina is active member of multiple surgical societies including the American Medical Association, American College of Surgeons, Society of Surgical Oncology, American Society of Clinical Oncology, American Cancer Society, American and International Hepato-Pacreato-Biliary Association, Society of Surgery for the alimentary tract. Recently, has been accepted as Fellow of the American College of Surgeons.
Dr. Pendas completed a Surgical Oncology Fellowship at the City of Hope National Medical Center in Duarte, California. During this time, she spent a year researching promising antitumor vaccines in addition to enhancing her surgical oncology experience. Her General Surgical Residency took place at Maimonides Medical Center in Brooklyn, New York. She augmented her Residency training by returning to Tampa to conduct research on breast cancer and hepatomas. She is a Magna Cum Laude graduate of the University of South Florida in Tampa, which is also where she attended Medical School.
Dr. Pendas is Board Certified in General Surgery and speaks fluent English and Spanish. She is a member of the Southeastern Surgical Congress, Society of Surgical Oncology and the American Medical Association. One of the many awards she has received has been the Gold Medal Paper: Southeastern Surgical Congress, February 1999 for Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. The American surgeon, Vol. 65, No. 6, June 1999.
Dr. Guerrier is board certified in Radiation Oncology by the American Board of Radiology. She completed a Radiation Oncology residency program at the Cancer Institute of New Jersey through the University of Medicine and Dentistry at Robert Wood Johnson Medical School. She also completed her Internal Medicine internship at Howard University Hospital in Washington, D.C.
During her residency training, Dr. Guerrier gained valuable experience in 3D Conformal Radiotherapy, IMRT, On Board Imaging, Brachytherapy, MammoSite, Gamma Knife Stereotactic Radiosurgery, and Intraoperative Radiotherapy.
Dr. Guerrier attended Rush Medical College in Chicago, IL. She spent a summer in Uganda, Africa through an NIH/MIRT Research Training Fellowship. She spent other summers throughout her medical training serving as a tutor, mentor and volunteer.
Dr. Guerrier has contributed to several publications, been involved in research activities and has presented during professional conferences. Professional memberships include: American Society for Therapeutic Radiology & Oncology, American Brachytherapy Society, Association of Residents in Radiological Oncology, Radiological Society of North America, American Association for Cancer Research, National Medical Association, Florida Medical Association, American Medical Association, Polk County Medical Association and the American College of Radiation Oncology.
Dr. Kamal Haider is Board Certified in Internal Medicine, Subspecialty Medical Oncology and Subspecialty Hematology.
He received his medical degree from King Edward Medical College in Lahore, Pakistan. After earning his degree, he completed an Internship in General Surgery/Medicine at Mayo Hospital in Lahore, Pakistan. He then completed his Residency in Internal Medicine at Woodhull Medical Center in New York City, New York, followed by a Fellowship in Hematology/Oncology at New York Medical College in Valhassa, New York.
He joined Clark & Daughtrey Medical Group, P.A. in January 1994.
Medical Oncology/Pain & Palliative Care Specialist
Dr. Nakka comes to Lakeland Regional Cancer Center from Maimonides Medical Center, where she completed Fellowship Training in Hematology and Oncology, Sub-Specializing in Breast Oncology. Prior to that she completed Fellowship Training in Pain and Palliative Care at Memorial Sloan-Kettering Cancer Center.
Dr. Nakka is Board-Certified in Hospice and Palliative Medicine, Pain Medicine, and Internal Medicine. She received Medicine and Surgery Degrees from the University of Health Sciences at Kakatiya Medical College in India and then completed certification through the Educational Commission of Foreign Medical Graduates.
Additional noteworthy experience includes a faculty position as Clinical Instructor in Pain and Palliative Care Service with the Department of Neurology at Memorial Sloan-Kettering Cancer Center, where she was involved with the fellowship-training program and served as principal investigator of several clinical trials. She also completed an Internal Medicine Residency at Mount Sinai School of Medicine.
Dr. Nakka has been involved in numerous research activities and studies, co-authored a paper and contributed to a medical publication. She speaks English, Hindi and Telugu and is involved with ASCO, ASH, American Medical Association, and American Academy of Hospice and Palliative Care.
Dr. Antonio Trindade is Board Certified in Internal Medicine. He received his medical degree from Cayetano Heredia University in Lima, Peru. He then participated in an Internship in Internal Medicine at Union Memorial Hospital in Baltimore, Maryland, followed by a Residency in Internal Medicine at Henry Ford Hospital in Detroit, Michigan.
Dr. Trindade completed his Fellowship in Oncology at M.D. Anderson Hospital in Houston, Texas, and also served as an Assistant Internist/Instructor at The University of Texas M.D. Anderson Hospital and Tumor Institute in Houston, Texas.
He joined Clark & Daughtrey Medical Group, P.A. in July 1985.
Dr. Venigalla is Sub-Specialty Board Certified in Medical Oncology and Hematology. She comes to LRCC from Fallon Clinic in Worcester, Massachusetts, where she also served at St. Vincent’s Hospital and Metro West Cancer Center. She has been involved with the residency teaching program and principal investigator of several trials at Metro West Medical Center. Prior to that she worked as an instructor at Beth Israel Deaconess Medical Center in Boston, Massachusetts.
Dr. Venigalla completed a Fellowship in Hematology/Oncology at the University of Massachusetts Medical Center, a Residency in Internal Medicine at University of Massachusetts Medical Center Memorial Health Care, and an Internship at Metro West Medical Center. She attended medical school at Kakatiya Medical College in Warangal, India.
Richard “Rusty” Boothby, MD, Gynecologic Oncologist, practices medicine with the goal of providing quality medical and surgical care to all women. He believes that quality care begins with patient education and that each individual should have access to the latest advances in medical care and investigational clinical trials. In addition, he believes all aspects of cancer care should consider quality of life and respect for each patient’s dignity.
Dr. Boothby is certified by the American Board of Obstetrics and Gynecology with a sub-specialty certification in Gynecologic Oncology. He is also certified by the Association of Clinical Research Professionals.
Dr. Boothby offers his patients a full array of radical and ultra-radical surgical procedures for treatment of their gynecologic cancers. He is also proficient in minimally invasive surgical procedures including DaVinci Robotic and Laparoscopic surgery when appropriate for gynecologic patients.
Dr. Boothby completed a Fellowship in Gynecologic Oncology at the Hospital of the University of Pennsylvania and a residency in Obstetrics and Gynecology at the University of Florida at Jacksonville. He received his Medical Degree from the University of South Florida.
He serves as a Courtesy Clinical Associate Professor of Obstetrics and Gynecology at the University of Florida and has served as Assistant Professor of Obstetrics and Gynecology at Cornell University Medical College.
Previous honors and activities include serving in various leadership positions of the Florida Society of Gynecologic Oncology (President from 2004-2006), Director of Clinical Research at MD Anderson Cancer Center Orlando, and multiple faculty teaching awards. Dr. Boothby has authored or co-authored more than 15 peer-reviewed scientific publications.